Lasis Pharmaceuticals Private Limited
About Lasis Pharmaceuticals Private Limited
Data last updated:
Lasis Pharmaceuticals Private Limited is a private limited company based in Darbhanga, Bihar, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 06 January 2023.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24304BR2023PTC061526.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Hritik Kumar Agrawal and Amrita.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Ganesh Agrawal K.M. Tank Uttarbari Bhinda Laheriasarai, Darbhanga, Bihar, India – 846001.
As per the financials filed for FY 2025, the company reported a revenue of ₹62,451, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4,301 (net margin 6.9%) and EBITDA of ₹5,101 (EBITDA margin 8.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lasis Pharmaceuticals Private Limited's registered office is in Darbhanga, Bihar.
- Registered AddressC/O Ganesh Agrawal K.M. Tank Uttarbari Bhinda Laheriasarai, Darbhanga, Bihar, India – 846001
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Lasis Pharmaceuticals Private Limited
FY 2025 filings availableLasis Pharmaceuticals Private Limited reported revenue of ₹62,451 (up 217% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 217% in the latest year. EBITDA rose 187% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹5,101 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹4,301 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 8.2% | ||
| Net Profit Margin | 6.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Lasis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lasis Pharmaceuticals Private Limited
Lasis Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hritik Kumar Agrawal | Director | 06 Jan 2023 | 3 Years 10 Months | Current |
| Amrita | Director | 06 Jan 2023 | 3 Years 10 Months | Current |
| Roushan Kumar Jha | Director | 06 Jan 2023 | 3 Years 10 Months | Current |
Peer comparison
Lasis Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mont Pharmaceuticals Private Limited | ₹64,828 (FY 2025) | New Delhi, Delhi, India | ||||
| Expergen Pharmaceuticals Private Limited | ₹63,630 (FY 2020) | 10.0% | Andheri East Mumbai, Maharashtra, India | |||
| Magisca Pharmaceuticals Private Limited | ₹63,622 (FY 2025) | -33.0% | New Delhi, Delhi, India | |||
| Pushkar Pharmaceuticals Pvt Ltd | ₹63,000 (FY 2024) | 23.0% | Chandigarh, India | |||
| Mankem Pharmaceuticals Private Limited | ₹62,976 (FY 2025) | -20.0% | Jehanabad, Bihar, India | |||
| Lasis Pharmaceuticals Private Limitedthis company | ₹62,451 (FY 2025) | ₹4,301 | 6.9% | 217.0% | Darbhanga, Bihar, India | |
| Dalam Pharmaceuticals Private Limited | ₹62,450 (FY 2024) | -48.0% | Karimnagar, Telangana, India | |||
| Emsons Pharmaceuticals Pvt Ltd | ₹62,450 (FY 2020) | 13.0% | Kolkata, West Bengal, India | |||
| Amidi Pharmaceuticals Private Limited | ₹61,717 (FY 2022) | Patna, Bihar, India | ||||
| Halcyon Pharmaceuticals Limited | ₹61,632 (FY 2024) | -33.0% | Hisar, Haryana, India | |||
| Enmando Pharmaceuticals Private Limited | ₹61,500 (FY 2024) | -50.0% | Saidulajab, Delhi, India |
To see the full peer comparison of Lasis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lasis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lasis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lasis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lasis Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Amrita was appointed as Director on 06 Jan 2023.
Frequently asked questions
Lasis Pharmaceuticals is an active private limited company based in Darbhanga, Bihar, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 06 January 2023 (3+ years old) and is registered under CIN U24304BR2023PTC061526.
Lasis Pharmaceuticals has 3 current directors:
- Hritik Kumar Agrawal - Director
- Amrita - Director
- Roushan Kumar Jha - Director
The latest financial statements of Lasis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Lasis Pharmaceuticals is U24304BR2023PTC061526. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lasis Pharmaceuticals was incorporated on 06 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Lasis Pharmaceuticals by revenue are Mont Pharmaceuticals Private Limited, Expergen Pharmaceuticals Private Limited, Magisca Pharmaceuticals Private Limited, Pushkar Pharmaceuticals Pvt Ltd, Mankem Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Amrita was appointed as Director on 06 Jan 2023. Hritik Kumar Agrawal was appointed as Director on 06 Jan 2023. Roushan Kumar Jha was appointed as Director on 06 Jan 2023.
The registered office of Lasis Pharmaceuticals is at CO Ganesh Agrawal K.M. Tank Uttarbari Bhinda Laheriasarai, Darbhanga, Bihar, India – 846001.
Lasis Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.
The compliance status of Lasis Pharmaceuticals is compliant as of 31 August 2026. The company is actively filing with the Registrar of Companies.
Lasis Pharmaceuticals can be reached at its registered office: CO Ganesh Agrawal K.M. Tank Uttarbari Bhinda Laheriasarai, Darbhanga, Bihar, India – 846001.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
